Late Breaking Abstract - Does medication exacerbate comorbidities in chronic obstructive pulmonary disease? A prevalence study of neuroleptic intake

V. Cabibel (Montpellier, France), N. Héraud (Lodève, France), A. Varray (Montpellier, France), F. Alexandre (Lodève, France)

Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Session: COPD exacerbations and bronchiectasis
Session type: Thematic Poster
Number: 4086
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Cabibel (Montpellier, France), N. Héraud (Lodève, France), A. Varray (Montpellier, France), F. Alexandre (Lodève, France). Late Breaking Abstract - Does medication exacerbate comorbidities in chronic obstructive pulmonary disease? A prevalence study of neuroleptic intake. 4086

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index
Source: International Congress 2016 – Novel avenues in the treatment of COPD I
Year: 2016


Late Breaking Abstract - Co-morbid disease clusters in chronic obstructive pulmonary disease: the ERICA study
Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care
Year: 2017



Prescription of opioids for breathlessness in end-stage chronic obstructive pulmonary disease: A national population based study
Source: International Congress 2016 – Management of dyspnoea and exacerbations in chronic lung diseases
Year: 2016


Late Breaking Abstract - Economics burden and healthcare utilization in chronic obstructive pulmonary disease patients with or without sepsis.
Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness
Year: 2019

Late Breaking Abstract - Indacaterol/glycopyrronium versus salmeterol/fluticasone in chronic obstructive pulmonary disease: a meta-analysis on the protection against the risk of exacerbation
Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies
Year: 2019

Determinants of anxiety and depression among Filipino patients with chronic obstructive pulmonary disease: A multi-center study
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013

Survival of patients with severe chronic obstructive pulmonary disease in relation to smoking habits
Source: Annual Congress 2012 - Tobacco dependence and respiratory disease
Year: 2012


Doxycycline for exacerbations of chronic obstructive pulmonary disease in outpatients: who benefits?
Source: ERJ Open Res, 6 (2) 00099-2020; 10.1183/23120541.00099-2020
Year: 2020



Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


Acute exacerbations of chronic obstructive pulmonary disease: Impact of cardiovascular co-morbidities
Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Year: 2010


Prevalence of metabolic syndrome among patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015


Characteristics and consequences of chronic obstructive pulmonary disease in never smokers
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013

Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes?
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014


Prevalence of comorbid cardiovascular conditions in Russian patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 453s
Year: 2006

Predictors of exacerbations in chronic obstructive pulmonary disease - a first single-centre experience in Croatia
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020


Relationship between dyspnea and depression in the elderly patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Effects of an eHealth intervention promoting correct use of medication in patients with asthma and chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Remote monitoring of respiratory patients
Year: 2021



Is anxiety and depression a barrier to enrolment in a study in chronic obstructive pulmonary disease (COPD)?
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016

Chronic obstructive pulmonary disease - cardiovascular sequel of bronchodilation?
Source: International Congress 2018 – PG19 Heart-lung interaction
Year: 2018


Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014